1. Home
  2. PCVX vs KVYO Comparison

PCVX vs KVYO Comparison

Compare PCVX & KVYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • KVYO
  • Stock Information
  • Founded
  • PCVX 2013
  • KVYO 2012
  • Country
  • PCVX United States
  • KVYO United States
  • Employees
  • PCVX N/A
  • KVYO N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • KVYO
  • Sector
  • PCVX Health Care
  • KVYO
  • Exchange
  • PCVX Nasdaq
  • KVYO Nasdaq
  • Market Cap
  • PCVX 4.5B
  • KVYO 8.8B
  • IPO Year
  • PCVX 2020
  • KVYO 2023
  • Fundamental
  • Price
  • PCVX $31.16
  • KVYO $33.39
  • Analyst Decision
  • PCVX Strong Buy
  • KVYO Buy
  • Analyst Count
  • PCVX 10
  • KVYO 20
  • Target Price
  • PCVX $136.50
  • KVYO $42.40
  • AVG Volume (30 Days)
  • PCVX 2.2M
  • KVYO 2.6M
  • Earning Date
  • PCVX 05-07-2025
  • KVYO 05-06-2025
  • Dividend Yield
  • PCVX N/A
  • KVYO N/A
  • EPS Growth
  • PCVX N/A
  • KVYO N/A
  • EPS
  • PCVX N/A
  • KVYO N/A
  • Revenue
  • PCVX N/A
  • KVYO $1,007,298,000.00
  • Revenue This Year
  • PCVX N/A
  • KVYO $25.98
  • Revenue Next Year
  • PCVX N/A
  • KVYO $21.51
  • P/E Ratio
  • PCVX N/A
  • KVYO N/A
  • Revenue Growth
  • PCVX N/A
  • KVYO 33.95
  • 52 Week Low
  • PCVX $27.66
  • KVYO $21.26
  • 52 Week High
  • PCVX $121.06
  • KVYO $49.55
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 36.73
  • KVYO 60.44
  • Support Level
  • PCVX $28.09
  • KVYO $29.87
  • Resistance Level
  • PCVX $33.75
  • KVYO $34.13
  • Average True Range (ATR)
  • PCVX 2.54
  • KVYO 1.68
  • MACD
  • PCVX 1.12
  • KVYO 0.83
  • Stochastic Oscillator
  • PCVX 35.61
  • KVYO 92.86

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

Share on Social Networks: